TD Ameritrade Investment Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-17
| Closed | -$1K | – | 188 |
|
|
2023
Q2 | $1K | Hold |
17
| – | – | ﹤0.01% | 509 |
|
|
2023
Q1 | $1K | Sell |
17
-33
| -66% | -$1.94K | ﹤0.01% | 547 |
|
|
2022
Q4 | $2K | Sell |
50
-264
| -84% | -$10.6K | ﹤0.01% | 490 |
|
|
2022
Q3 | $9K | Sell |
314
-149
| -32% | -$4.27K | ﹤0.01% | 392 |
|
|
2022
Q2 | $25K | Sell |
463
-624
| -57% | -$33.7K | ﹤0.01% | 365 |
|
|
2022
Q1 | $59K | Buy |
1,087
+507
| +87% | +$27.5K | ﹤0.01% | 336 |
|
|
2021
Q4 | $32K | Buy |
580
+411
| +243% | +$22.7K | ﹤0.01% | 384 |
|
|
2021
Q3 | $8K | Sell |
169
-95
| -36% | -$4.5K | ﹤0.01% | 466 |
|
|
2021
Q2 | $13K | Buy |
264
+39
| +17% | +$1.92K | ﹤0.01% | 429 |
|
|
2021
Q1 | $10K | Hold |
225
| – | – | ﹤0.01% | 451 |
|
|
2020
Q4 | $10K | Buy |
225
+56
| +33% | +$2.49K | ﹤0.01% | 451 |
|
|
2020
Q3 | $8K | Hold |
169
| – | – | ﹤0.01% | 466 |
|
|
2020
Q2 | $9K | Buy |
169
+15
| +10% | +$799 | ﹤0.01% | 438 |
|
|
2020
Q1 | $7K | Sell |
154
-13,873
| -99% | -$631K | ﹤0.01% | 456 |
|
|
2019
Q4 | $824K | Buy |
14,027
+877
| +7% | +$51.5K | 0.01% | 138 |
|
|
2019
Q3 | $702K | Buy |
13,150
+2,543
| +24% | +$136K | 0.01% | 147 |
|
|
2019
Q2 | $531K | Buy |
10,607
+2,053
| +24% | +$103K | ﹤0.01% | 147 |
|
|
2019
Q1 | $447K | Buy |
8,554
+2,612
| +44% | +$136K | ﹤0.01% | 141 |
|
|
2018
Q4 | $284K | Buy |
5,942
+2,365
| +66% | +$113K | ﹤0.01% | 141 |
|
|
2018
Q3 | $180K | Buy |
3,577
+3,210
| +875% | +$162K | ﹤0.01% | 141 |
|
|
2018
Q2 | $19K | Buy |
+367
| New | +$19K | ﹤0.01% | 192 |
|